Hong Kong Aerospace & Defense Stock News

SEHK:2228
SEHK:2228Life Sciences

XtalPi Holdings (SEHK:2228) TTM Profitability Challenges High P/S Market Narrative

XtalPi Holdings (SEHK:2228) has put fresh numbers on the table for FY 2025, with second half revenue of C¥285.5 million, basic EPS of C¥0.0103 and net income of C¥41.0 million. The latest trailing twelve month figures show revenue of C¥802.6 million, basic EPS of C¥0.0327 and net income of C¥123.7 million. Over the recent half year snapshots, revenue has moved from C¥163.8 million in 2H 2024 to C¥517.1 million in 1H 2025 and C¥285.5 million in 2H 2025. EPS shifted from a loss of C¥0.0893 in...
SEHK:6979
SEHK:6979Beverage

ZJLD Group (SEHK:6979) Margin Compression Challenges Bullish Growth Narratives

ZJLD Group (SEHK:6979) has released its FY 2025 results with first half revenue of C¥2.5b and basic EPS of C¥0.17, setting the tone for how the rest of the year could shape up. The company has seen revenue shift from C¥4.1b with EPS of C¥0.23 in the first half of FY 2024 to C¥2.9b and C¥0.17 respectively in the second half of FY 2024, before landing at C¥2.5b and C¥0.17 in the latest period. This puts the focus squarely on how effectively it can defend and rebuild margins from here. See our...
SEHK:6828
SEHK:6828Gas Utilities

Beijing Gas Blue Sky Holdings (SEHK:6828) Margin Compression Tests Bullish Earnings Narratives

Beijing Gas Blue Sky Holdings (SEHK:6828) has reported first half FY 2025 revenue of C¥1.0b and basic EPS of C¥0.002296, with trailing twelve month EPS up 2.5% and net income of C¥87.2m. Over the last year, revenue has moved from C¥1.7b to C¥1.9b on a trailing basis, while EPS has edged from C¥0.003741 to C¥0.0038 as net profit margins eased from 5.0% to 4.5%, setting up a results season in which modest earnings growth is balanced by pressure on profitability. See our full analysis for...
SEHK:6601
SEHK:6601Household Products

Cheerwin Group (SEHK:6601) Net Margin Holds At 11.3% Challenging Bearish Profitability Narratives

Cheerwin Group (SEHK:6601) has put fresh numbers on the table for FY 2025, with first half revenue of C¥1.3b and basic EPS of C¥0.13, against a trailing twelve month picture that shows revenue of C¥2.0b and EPS of C¥0.17 alongside earnings growth of 10% over the past year. The company has seen recent half year revenue move from C¥1.25b in 2024 H1 to C¥1.34b in 2025 H1, while basic EPS has remained at C¥0.13 over the same periods, setting the stage for investors to weigh that trajectory...
SEHK:3988
SEHK:3988Banks

Bank Of China Tier 2 Bond Redemption Reshapes Capital Stack Outlook

Bank of China has exercised its redemption right on a RMB 15b tranche of Tier 2 capital bonds issued in 2021. The full redemption affects the bank's mix of regulatory capital and could influence its future funding costs. This move reflects an active approach to managing its capital structure and overall financial flexibility. For investors watching Bank of China (SEHK:3988), this capital action comes with the shares trading at HK$4.84 and showing a 6.8% return year to date and an 11.0%...
SEHK:1024
SEHK:1024Interactive Media and Services

Kuaishou Technology (SEHK:1024) Q4 Net Margin Of 13% Challenges Bearish Profitability Concerns

Kuaishou Technology (SEHK:1024) has wrapped up FY 2025 with fourth quarter revenue of C¥39.6b and basic EPS of C¥1.22, against trailing 12 month revenue of C¥142.8b and EPS of C¥4.35 that came with 21.4% earnings growth over the prior year. Over recent periods, revenue has moved from C¥35.4b in Q4 2024 to C¥39.6b in Q4 2025, while quarterly basic EPS has shifted from C¥0.93 to C¥1.22, presenting a set of results where a 13% net profit margin and improving earnings trends are front and centre...
SEHK:2285
SEHK:2285Consumer Durables

Chervon Holdings FY 2025 EPS Rebound Challenges Long Term 5% Earnings Decline Narrative

Chervon Holdings (SEHK:2285) has just posted its FY 2025 first half results, reporting revenue of US$912.4 million and basic EPS of US$0.19. These figures frame how investors may interpret the latest profitability and margin picture. The company’s revenue increased from US$815.7 million in the first half of FY 2024 to US$912.4 million in the first half of FY 2025, while basic EPS rose from US$0.12 to US$0.19 over the same periods. This provides a clearer view of how the top line and per share...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Cloud CGTrader 3D AI Deal Adds Angle To Tencent Valuation

Tencent Cloud and CGTrader announced a partnership at MWC 2026 to power an AI driven 3D asset creation workflow. The deal integrates Tencent Cloud's HY 3D Global solution into CGTrader's platform for automated 3D content production. The collaboration targets global clients that rely on large scale 3D libraries for gaming, ecommerce, and virtual experiences. For investors following Tencent Holdings (SEHK:700), this move extends the company further into AI supported content creation, an area...
SEHK:511
SEHK:511Media

Tvb Sehk511 Return To Trailing Profitability Tests Bullish Growth Narratives

Television Broadcasts (SEHK:511) has just posted its FY 2025 first half numbers, with revenue of HK$1,497.8 million and a basic EPS loss of HK$0.23, while trailing twelve month figures show revenue of HK$3.2 billion and basic EPS of HK$0.13. Over the past year, the company has seen revenue remain in the HK$3.2 billion range on a trailing basis, with net income shifting from a loss of HK$491.0 million in the prior trailing period to a profit of HK$59.3 million. This points to a clear swing in...
SEHK:3329
SEHK:3329Capital Markets

BOCOM International Holdings SEHK 3329 Loss Of HK$282.6 Million Tests Value Narrative

BOCOM International Holdings (SEHK:3329) has opened FY 2025 with first half revenue of HK$13.7 million and a basic EPS loss of HK$0.10, setting a cautiously watchful tone around its current share price of HK$0.34. Over the past three reported halves, total revenue has shifted from a loss of HK$71.3 million in 1H 2024 to a loss of HK$305.2 million in 2H 2024, before landing at HK$13.7 million in 1H 2025. Basic EPS moved from a loss of HK$0.13 to a loss of HK$0.32 and then to a loss of HK$0.10...
SEHK:2507
SEHK:2507Aerospace & Defense

Cirrus Aircraft (SEHK:2507) EPS Holds At US$0.18 Challenging High Growth Narratives

Cirrus Aircraft (SEHK:2507) posts FY 2025 first half earnings Cirrus Aircraft (SEHK:2507) has opened FY 2025 with first half revenue of US$594.5 million and basic EPS of US$0.18, setting the stage against trailing twelve month revenue of about US$1.35 billion and EPS of roughly US$0.38 as investors assess how the latest numbers fit into the broader earnings story. Over the past three reported halves, revenue has moved from US$475.4 million in 1H FY 2024 to US$721.7 million in 2H FY 2024 and...
SEHK:9860
SEHK:9860Healthcare

Adicon Holdings (SEHK:9860) Thin 0.7% Margin Tests High Growth And Valuation Narratives

Adicon Holdings FY 2025 earnings snapshot Adicon Holdings (SEHK:9860) just posted its FY 2025 first half results, with revenue of about C¥1.3b and basic EPS of C¥0.04. This helps frame how the rest of the year might shape investor expectations. The company reported revenue of C¥1.47b in the first half of FY 2024 and C¥1.27b in the first half of FY 2025, while EPS moved from C¥0.14 to C¥0.04 over the same period, offering a clear view of how the top and bottom lines have tracked through the...
SEHK:2628
SEHK:2628Insurance

China Life Insurance (SEHK:2628) Q4 Loss Challenges Bullish Earnings Growth Narrative

China Life Insurance (SEHK:2628) has wrapped up FY 2025 with a mixed final quarter, reporting Q4 revenue of CNY 39.3b and a basic EPS loss of CNY 0.48, set against trailing 12 month EPS of CNY 5.45 on revenue of CNY 352.1b. Investors are weighing recent 44.1% earnings growth and a net profit margin of 43.8% against forecasts of an 8.1% annual earnings decline over the next three years. Over recent periods the company has seen quarterly revenue move from CNY 58.9b in Q4 2024 to CNY 64.3b in Q1...
SEHK:3316
SEHK:3316Commercial Services

Binjiang Service Group (SEHK:3316) EPS Growth Reinforces Bullish Narratives Despite Margin Slippage

Binjiang Service Group (SEHK:3316) has reported its FY 2025 first half with total revenue of ¥2.0b and basic EPS of ¥1.08, setting the tone for a results season where the topline and per share earnings are both clearly quantified. Over the last three reported halves, revenue has moved from ¥1,650.4m in 1H 2024 to ¥1,944.3m in 2H 2024 and now ¥2,025.0m in 1H 2025. Basic EPS over those same periods has gone from ¥0.96 to ¥1.02 and then to ¥1.08, giving you a clear view of how the income...
SEHK:2488
SEHK:2488Auto Components

Launch Tech (SEHK:2488) Margin Decline To 16.3% Tests Bullish Profitability Narrative

Launch Tech (SEHK:2488) has put fresh numbers on the table for FY 2025, with first half revenue of C¥981.7 million and basic EPS of C¥0.47. These results sit against a longer history of earnings growth of 39.7% per year over the past five years and 1.4% over the last twelve months. Over recent periods the company has reported revenue of C¥894.5 million in 2024 H1, C¥883.0 million in 2024 H2 and C¥981.7 million in 2025 H1. Over the same halves, basic EPS has shifted from C¥0.37 to C¥0.45 to...
SEHK:2020
SEHK:2020Luxury

Anta Sports (SEHK:2020) Margin Compression Challenges Bullish Multi Year Earnings Narrative

ANTA Sports Products (SEHK:2020) has just posted its FY 2025 numbers, with second half revenue of C¥41.7b, basic EPS of C¥2.36 and net income of C¥6.6b, set against a trailing 12 month picture showing C¥80.2b in revenue, basic EPS of C¥4.89 and net income of C¥13.6b as margins eased from 22% to 16.9%. The company has seen revenue move from C¥37.1b and basic EPS of C¥2.81 in the second half of 2024 to C¥41.7b and C¥2.36 in the second half of 2025. Over the same period, trailing 12 month EPS...
SEHK:2660
SEHK:2660Entertainment

Zengame Technology Holding Margins Slip To 22.5% Challenging Bullish Valuation Narratives

Zengame Technology Holding (SEHK:2660) has opened FY 2025 with first half revenue of C¥709.1 million and basic EPS of C¥0.181. This compares with prior half year figures of C¥723.4 million revenue and EPS of C¥0.120 for 2H 2024, and C¥934.3 million revenue and EPS of C¥0.307 for 1H 2024. Over the trailing twelve months, revenue has ranged from C¥1.432 billion to C¥1.658 billion, with basic EPS moving between C¥0.301 and C¥0.427. This sets a mixed backdrop for interpreting the latest results...
SEHK:1601
SEHK:1601Diversified Financial

Zhongguancun Science Tech Leasing SEHK 1601 Margin Decline Challenges Bullish Growth Narratives

Latest FY 2025 Earnings Snapshot Zhongguancun Science-Tech Leasing (SEHK:1601) has wrapped up FY 2025 with fourth quarter revenue of C¥34.2 million and net income of C¥57.3 million, set against trailing twelve month revenue of C¥619.8 million, net income of C¥272.0 million and EPS of C¥0.18. Over recent periods, the company has seen quarterly revenue swing between C¥63.2 million and C¥329.0 million, while EPS has ranged from C¥0.0426 to C¥0.0531. The latest twelve month net profit margin sits...
SEHK:1762
SEHK:1762Interactive Media and Services

Wanka Online (SEHK:1762) Earnings Surge Tests Justification For Rich 50x P/E Premium

Wanka Online (SEHK:1762) has reported FY 2025 results that put revenue and earnings firmly in focus, with first half revenue of C¥1.7b and basic EPS of C¥0.03, alongside trailing 12 month basic EPS of C¥0.03 and very large year over year earnings growth of 2,469.9%. Over recent periods, the company has seen revenue move from C¥1.2b in 2024 H1 to C¥1.4b in 2024 H2 and then to C¥1.7b in 2025 H1. Over the same timeframe, basic EPS shifted from C¥0.03 in 2024 H1 to a loss of C¥0.03 in 2024 H2...
SEHK:1516
SEHK:1516Real Estate

Sunac Services Holdings SEHK 1516 Margin Recovery To CN¥121.9m Profit Tests Bearish Narratives

Sunac Services Holdings FY 2025 Earnings Snapshot Sunac Services Holdings (SEHK:1516) has reported its FY 2025 numbers with first half revenue of CN¥3,546.6 million and basic EPS of CN¥0.04, while trailing twelve month revenue sits at CN¥6,816.2 million and EPS at CN¥0.07 as the business moves away from prior losses. Over the last three reported half year periods, revenue has held close to the CN¥3,480 million to CN¥3,550 million range, while EPS has swung from a loss of CN¥0.15 in 1H 2024 to...
SEHK:1816
SEHK:1816Renewable Energy

CGN Power (SEHK:1816) Q4 EPS Slide Reinforces Bearish Valuation Narratives

CGN Power (SEHK:1816) has wrapped up FY 2025 with fourth quarter revenue of about C¥16.0b and basic EPS of C¥0.023, while trailing twelve month revenue stood at roughly C¥75.7b with EPS of C¥0.193. Over recent periods, quarterly revenue has ranged from about C¥16.0b to C¥20.6b, with basic EPS moving between C¥0.023 and C¥0.06. This sets the backdrop for trailing net income of roughly C¥9.8b. With net profit margins ticking up slightly to 12.9% on a trailing basis, the latest results highlight...
SEHK:6996
SEHK:6996Pharmaceuticals

3 Global Penny Stocks With Market Caps Under US$900M To Watch

Global markets have been navigating a challenging landscape marked by geopolitical tensions, fluctuating oil prices, and persistent inflation concerns. Amidst this backdrop, the concept of penny stocks remains relevant as these smaller or newer companies can offer unique growth opportunities at lower price points. When backed by strong financial health and solid fundamentals, penny stocks can present underappreciated chances for significant returns.
SEHK:9926
SEHK:9926Biotechs

Akeso Advances Next Generation Oncology Pipeline With New Trial Clearances

Akeso received regulatory clearance in China to start Phase II trials for two next generation antibody drug conjugates, AK146D1 and AK138D1, in oncology. The company also secured clearance for AK150, a globally first in class trispecific antibody, to begin clinical trials in patients with advanced solid tumors. These approvals move multiple assets in Akeso's pipeline into clinical and mid stage development. For investors tracking Akeso (SEHK:9926), these clearances come with the stock...
SEHK:6990
SEHK:6990Biotechs

Sichuan Kelun-Biotech’s SKB103 IND Adds ADC Momentum And Valuation Upside

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has received IND approval in China for SKB103, its first TAA PD-L1 bispecific antibody-drug conjugate. SKB103 becomes the company’s second bispecific ADC to reach the clinical stage, following SKB571. The candidate is built on Kelun-Biotech’s proprietary OptiDC™ platform and is designed to combine tumor antigen targeting with PD-L1 immune modulation. For investors tracking SEHK:6990, the IND clearance for SKB103 adds another clinical stage...